A stress response allows organisms to respond appropriately to a continually changing environment. Many diverse species have a stress response, emphasizing that this mechanism is conserved and integral for survival. The stress response includes the release of epinephrine (adrenaline) through the sympathetic nervous system, which Walter Cannon (1871–1945) described as mediating the flight-or-fight response to escape or face a threat. This system redistributes energy resources to tissues that need them (skeletal muscles, heart) from those functions that can be temporarily delayed (digestive and reproductive systems). The stress response also includes the hypothalamic-pituitary-adrenal (HPA) axis. The hypothalamus releases corticotrophin-releasing hormone and arginine vasopressin into a local hypophyseal portal blood system, which stimulates the anterior pituitary to release adrenocorticotropin hormone (ACTH) into the general blood supply. ACTH triggers the adrenal gland to release GCs, which include corticosterone in rats and mice and cortisol in humans and primates. GCs complement the sympathetic nervous system response by mobilizing energy stores to provide energy substrates within the blood, in addition to many other actions that include inhibiting inflammatory responses. These events necessitate that GCs be tightly regulated by inhibitory feedback mechanisms at the hypothalamus and pituitary, as well as at higher cognitive neural structures (for review, see
Herman, Figueiredo, et al., 2003).
Chronically activating the stress response can produce maladaptive changes, which have been postulated to contribute to disease (for review, see
de Kloet, Joels, & Holsboer, 2005;
McEwen & Wingfield, 2003;
Smith, 1996). A transition into maladaptive changes includes dendritic remodeling, which can be produced under a variety of chronic stress conditions: 6 hours of daily restraint in wire mesh for 21 days (
Watanabe, Gould, Cameron, et al., 1992;
Watanabe, Gould, Daniels, et al., 1992;
Watanabe, Gould, & McEwen, 1992), daily predator stress combined with a high-fat diet for 21 days (
Baran et al., 2005), social defeat stress every other day for 21 days (
Kole, Costoli, Koolhaas, & Fuchs, 2004), continual social stress and competition for resources over 14 days (
McKittrick et al., 2000), 2 hours in bag restraints daily for 10 days (
Vyas, Mitra, Rao, & Chattarji, 2002), and daily activity stress combined with food restriction over 6 days (
Lambert et al., 1998). Although chronic stress predominately reduces dendritic arbors in CA3 neurons, dendritic retraction has been observed in other brain regions. When chronic unpredictable stress continues for 4 weeks, CA1 and dentate gyrus neurons express dendritic retraction (
Sousa, Lukoyanov, Madeira, Almeida, & Paula-Barbosa, 2000). In addition, CA3 and CA1 dendritic retraction occurs in as little as 6 days following activity stress combined with food restriction (
Lambert et al., 1998). Prefrontal cortical neurons also express dendritic retraction following 3 hours of restraint for 1 to 3 weeks (S. M.
Brown, Henning, & Wellman, 2005;
Radley et al., 2004). Chronic stress-induced CA3 dendritic remodeling has been proposed to be a maladaptive response because it is associated with susceptibility to damage and cognitive dysfunction (discussed later). However, another interpretation is that CA3 dendritic remodeling may be a compensatory response to protect against extended excitatory amino acid stimulation, which can compromise and kill neurons.
The mechanism underlying stress-induced CA3 dendritic retraction is illustrated in and is discussed in other reviews (
McEwen, Magarinos, & Reagan, 2002;
Smith, 1996). GCs acting through the GR mediate stress-induced CA3 dendritic retraction. Chronic administration of stress levels of GCs produces CA3 dendritic retraction (
Magariños, Orchinik, & McEwen, 1998;
Woolley, Gould, & McEwen, 1990), and GC attenuation with cyanoketone blocks CA3 dendritic retraction (
Magariños & McEwen, 1995b). These studies indicate that corticosterone, rather than other hormones of the HPA axis or enhanced activity of the sympathetic nervous system, mediates CA3 dendritic retraction.
Excitatory amino acid release influences stress-induced CA3 dendritic retraction. Phenytoin (Dilantin), an antiepileptic that interferes with excitatory amino acid release and action (
Crowder & Bradford, 1987;
Griffith & Taylor, 1988;
Skerritt & Johnston, 1983), prevents stress-induced CA3 dendritic retraction (
Magariños et al., 1996;
Watanabe, Gould, Cameron, et al., 1992). These data are consistent with stress-enhancing glutamate release (
Gilad, Gilad, Wyatt, & Tizabi, 1990;
Lowy, Gault, & Yamamoto, 1993) and up-regulating glutamate transporter expression within glia of the CA3 region (
Reagan et al., 2004).
Selective changes in regions showing dendritic remodeling may help identify glutaminergic afferents contributing to CA3 dendritic plasticity following chronic stress because glutaminergic afferents are topographically organized. The mossy fibers from the dentate gyrus granule cells form synapses on excrescences, postsynaptic structures located proximal to the CA3 soma (T. H.
Brown & Zador, 1990;
Martinez & Barea-Rodriguez, 1997). Afferents located distally from the CA3 soma form synapses on “spines” and include the commissural fibers from the contralateral hippocampus, recurrent axon collaterals from CA3 neurons, and the perforant path from the entorhinal cortex (T. H.
Brown & Zador, 1990;
Martinez & Barea-Rodriguez, 1997;
Witter & Amaral, 2004). Chronic stress produces drastic remodeling within the middle part of the apical CA3 dendritic tree (
Kole et al., 2004), which corresponds to the region expressing chronic stress-induced changes in the N-methyl-D-aspartate (NMDA) glutaminergic receptor sensitivity (
Kole, Swan, & Fuchs, 2002). Consequently, these two studies implicate the commissural-associational collaterals as contributing to CA3 dendritic retraction. Another study showed that entorhinal cortical lesions, which project to the distal portions of the apical CA3 region, protect against CA3 dendritic retraction following chronic stress (
Sunanda, Meti, & Raju, 1997). Moreover, dendritic retraction typically occurs on the CA3 apical region, not the CA3 basal tree (
Conrad et al., 1999;
Magariños et al., 1996;
Magariños & McEwen, 1995a;
McKittrick et al., 2000), and the former region receives the majority of mossy fiber inputs from the dentate gyrus, indicating that selective damage to the dentate may also prevent stress-induced CA3 dendritic remodeling. Dendritic retraction has been observed in both the apical and basal regions, but this robust dendritic retraction typically occurs under extreme conditions that combine chronic restraint with food restriction (
Kleen, Sitomer, Killeen, & Conrad, in press) or ovariectomy in females (
McLaughlin, Baran, Wright, & Conrad, 2005). Finally, chronic stress-induced decreases in CA3 dendritic complexity occur in conjunction with increased density of both excrescences and spines (
Sunanda, Rao, & Raju, 1995), implicating compensatory mechanisms of both mossy fiber and nonmossy fiber afferents. Altogether, these studies indicate that chronic stress interacts synergistically with a variety of glutaminergic afferents to remodel CA3 dendritic morphology.
Serotonin may be implicated in CA3 dendritic retraction. Chronic stress increases brain serotonergic levels (
Chaouloff, 1993) and down-regulates the transporters that remove serotonin from the synapse, a process that can enhance extracellular serotonin (
McKittrick et al., 2000). Reducing extracellular serotonin by enhancing its uptake with tianeptine prevents stress-induced CA3 dendritic retraction (see ;
Conrad et al., 1999;
Magariños, Deslandes, & McEwen, 1999;
Watanabe, Gould, Daniels, et al., 1992). Antidepressants that enhance serotonin, such as fluoxetine, fail to alter stress-induced CA3 dendritic retraction (
Magariños et al., 1999). However, recent studies suggest that tianeptine may prevent CA3 dendritic retraction through actions on the glutaminergic system (
Fuchs, Czeh, Kole, Michaelis, & Lucassen, 2004;
McEwen & Chattarji, 2004), which includes altering NMDA receptor sensitivity (
Kole et al., 2002) and changed expression of glutamate transporter within glial cells (
Reagan et al., 2004). These studies show that enhanced serotonergic tone, or perhaps actions on the glutaminergic system, contributes to chronic stress-induced CA3 dendritic retraction.
Enhancing the inhibitory tone may also attenuate stress-induced CA3 dendritic retraction. The majority of interneurons within the hippocampus are inhibitory (
Feldblum, Erlander, & Tobin, 1993;
Woodson, Nitecka, & Ben-Ari, 1989), and activating gamma-aminobutyric acid (GABA)
A receptors with adinazolam, a benzodiazepine agonist, block CA3 dendritic retraction caused by chronic stress (
Magariños et al., 1999). Paradoxically, chronic stress enhances GABAergic systems (
Bowers, Cullinan, & Herman, 1998;
Qin, Karst, & Joels, 2004), but these effects may be region specific. For example, GABA can be altered within the interneurons of the dentate gyrus without changing GABA in other hippocampal regions (
Herman, Renda, & Bodie, 2003). This latter finding supports the interpretation that altered inhibitory tone is not uniform and that region-specific effects may disrupt overall inhibitory tone.
Neurotrophic factors, such as brain-derived neurotrophic factor (BDNF), nerve growth factor (NGF), neurotrophin (NT)–3, and NT-4, can also contribute to hippocampal dendritic plasticity. Postsynaptic neurons release neurotrophic factors, which are retrogradely transported to the nucleus of the presynaptic neuron to influence gene expression (
Smith, 1996). The hippocampus expresses the highest levels of BDNF mRNA in the brain (
Hofer, Pagliusi, Hohn, Leibrock, & Barde, 1990), and BDNF promotes neuronal connectivity (
Klintsova & Greenough, 1999;
Lewin & Barde, 1996), especially dendritic differentiation and complexity in nonpyramidal interneurons of the hippocampus (
Marty et al., 1996;
Vicario-Abejon, Collin, McKay, & Segal, 1998), neocortex (
Jin, Hu, Mathers, & Agmon, 2003), striatum (
Ventimiglia, Mather, Jones, & Lindsay, 1995), and cerebellum (
Mertz, Koscheck, & Schilling, 2000). Indeed, GABAergic influence is facilitated by BDNF and prevented by BDNF inhibitors (
Jin et al., 2003). Although chronic stress also enhances GABAergic systems (
Bowers et al., 1998), stress or isolation down-regulates BDNF (
Scaccianoce et al., 2006) and up-regulates NGF and NT-3 (
Smith, Makino, Kvetnansky, & Post, 1995). The effects of stress on NGF and NT-3 are proposed to be compensatory mechanisms (
Smith, 1996). Overall, many of the changes produced by BDNF are opposite those produced by glutamate and chronic stress (
Smith, 1996).
To demonstrate that many pharmacological manipulations do not act as antiglucocorticoids, other parameters of chronic stress perception are measured to demonstrate that drug actions work downstream from GC release. Chronic stress commonly decreases the weights of the thymus (
Bhatnagar & Meaney, 1995;
McKittrick et al., 2000) and gonads (
Galea et al., 1997) and the rate of body weight gain (
Conrad, Mauldin-Jourdain, & Hobbs, 2001;
Galea et al., 1997;
McKittrick et al., 2000;
Watanabe, Gould, Daniels, et al., 1992;
Watanabe, Gould, & McEwen, 1992;
Wright & Conrad, 2005) while increasing the weight of the adrenals (
McKittrick et al., 2000;
Watanabe, Gould, Daniels, et al., 1992;
Watanabe, Gould, & McEwen, 1992). On some occasions, chronic stress fails to alter the weight of a given target, but the rate of body weight gain tends to be highly reliable (as examples, see
Magariños & McEwen, 1995a,
1995b;
Vyas et al., 2002). In general, measures from several targets are helpful in demonstrating that the subjects perceive the procedure as stressful.